Works by Trudel, Suzanne

Results: 61

Effect of Noncompetitive Proteasome Inhibition on Bortezomib Resistance.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 14, p. 1069, doi. 10.1093/jnci/djq198
By:
- Xiaoming Li;
- Wood, Tabitha E.;
- Sprangers, Remco;
- Jansen, Gerrit;
- Franke, Niels E.;
- Xinliang Mao;
- Xiaoming Wang;
- Yi Zhang;
- Verbrugge, Sue Ellen;
- Adomat, Hans;
- Zhi Hua Li;
- Trudel, Suzanne;
- Chen, Christine;
- Religa, Tomasz L.;
- Jamal, Nazir;
- Messner, Hans;
- Cloos, Jacqueline;
- Rose, David R.;
- Navon, Ami;
- Guns, Emma
Publication type:
Article
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2
By:
- McCurdy, Arleigh;
- Reece, Donna;
- Louzada, Martha L.;
- White, Darrell;
- Parkin, Stephen;
- Chu, Michael P.;
- Kotb, Rami;
- Mian, Hira;
- Othman, Ibraheem;
- Su, Jiandong;
- Khan, Aniba;
- Gul, Engin;
- Trudel, Suzanne
Publication type:
Article
The Impact of CD34<sup>+</sup> Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 850, doi. 10.1016/j.clml.2023.07.014
By:
- Lebel, Eyal;
- Lajkosz, Katherine;
- Masih-Khan, Esther;
- Reece, Donna;
- Trudel, Suzanne;
- Tiedemann, Rodger;
- Prica, Anca;
- Kukreti, Vishal;
- Chen, Christine
Publication type:
Article
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. e97, doi. 10.1016/j.clml.2022.11.007
By:
- Khan, Sahar;
- Reece, Donna;
- Atenafu, Eshetu G.;
- Bhella, Sita;
- Chen, Christine;
- Masih-Khan, Esther;
- Paul, Harminder;
- Prica, Anca;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Kukreti, Vishal
Publication type:
Article
P-222: Extended follow-up safety and efficacy results of Belantamab mafodotin (Belamaf) 1.92 mg/kg or 2.5 mg/kg combined with POM and DEX for the treatment of relapsed/refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S162, doi. 10.1016/S2152-2650(21)02349-1
By:
- Trudel, Suzanne;
- McCurdy, Arleigh;
- Sutherland, Heather;
- Louzada, Martha;
- Venner, Christopher;
- White, Darrell;
- Hira Mian;
- Kotb, Rami;
- Othman, Ibraheem;
- Camacho, Fernando;
- Molei Fu;
- Engin Gul;
- Reece, Donna
Publication type:
Article
P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02346-6
By:
- Terpos, Evangelos;
- Badros, Ashraf Z.;
- Popat, Rakesh;
- Rodríguez-Otero, Paula;
- Farooq, Asim V.;
- Jeng, Bennie;
- Esposti, Simona Degli;
- Lewis, Eric;
- Gupta, Ira;
- Opalinska, Joanna;
- Palumbo, Antonio;
- Trudel, Suzanne;
- Jadhav, Vinay
Publication type:
Article
P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9
By:
- Richardson, Paul G.;
- Trudel, Suzanne;
- Callander, Natalie S.;
- Nooka, Ajay;
- Song, Kevin;
- Uttervall, Katarina;
- Minnema, Monique C.;
- Rodríguez-Otero, Paula;
- Struemper, Herbert;
- Yeakey, Anne;
- de Oca, Rocio Montes;
- Smith, L. Mary;
- Jackson, Nicola;
- Kaisermann, Morrys;
- Im, Ellie;
- Basile, Frank G.;
- Ahlers, Christoph M.;
- Holkova, Beata;
- Gupta, Ira;
- Kremer, Brandon E.
Publication type:
Article
P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S139, doi. 10.1016/S2152-2650(21)02314-4
By:
- Ayers, Dieter;
- Cope, Shannon;
- Dhanda, Devender S.;
- Towle, Kevin;
- Mojebi, Ali;
- Delforge, Michel;
- Rodríguez-Otero, Paula;
- Trudel, Suzanne;
- Weisel, Katja;
- Zamagni, Elena;
- Hari, Parameswaran
Publication type:
Article
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02100-5
By:
- Dholaria, Bhagirathbhai;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Solh, Melhem;
- Levy, Moshe;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S439, doi. 10.1016/S2152-2650(21)01978-9
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Hoi Kei Lon;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01944-3
By:
- Terpos, Evangelos;
- Badros, Ashraf;
- Popat, Rakesh;
- Rodriguez-Otero, Paula;
- Farooq, Asim;
- Jeng, Bennie;
- Esposti, Simona Degli;
- Lewis, Eric;
- Gupta, Ira;
- Opalinska, Joanna;
- Palumbo, Antonio;
- Trudel, Suzanne
Publication type:
Article
Poster: MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01577-9
By:
- Terpos, Evangelos;
- Badros, Ashraf;
- Popat, Rakesh;
- Rodriguez-Otero, Paula;
- Farooq, Asim;
- Jeng, Bennie;
- Esposti, Simona Degli;
- Lewis, Eric;
- Gupta, Ira;
- Opalinska, Joanna;
- Palumbo, Antonio;
- Trudel, Suzanne
Publication type:
Article
Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01578-0
By:
- Levy, Moshe;
- Bahlis, Nizar;
- Raje, Noopur;
- Costello, Caitlin;
- Dholaria, Bhagirathbhai;
- Solh, Melhem;
- Tomasson, Michael;
- Dube, Harman;
- Damore, Michael;
- Lon, Hoi Kei;
- Basu, Cynthia;
- Skoura, Athanasia;
- Chan, Edward;
- Trudel, Suzanne;
- Jakubowiak, Andrzej;
- Chu, Michael;
- Gasparetto, Cristina;
- Dalovisio, Andrew;
- Sebag, Michael;
- Lesokhin, Alexander
Publication type:
Article
Symptomatic BK Virus Disease in Patients With Heavily Pretreated Multiple Myeloma.
Published in:
2021
By:
- Lebel, Eyal;
- Chen, Christine;
- Paul, Harminder;
- Trudel, Suzanne;
- Tiedemann, Rodger
Publication type:
journal article
A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e53, doi. 10.1016/j.clml.2019.09.081
By:
- Spencer, Andrew;
- Rosenberg, Aaron Seth;
- Jakubowiak, Andrzej;
- Raje, Noopur;
- Chatterjee, Manik;
- Trudel, Suzanne;
- Bahlis, Nizar J.;
- Siegel, David S.;
- Wilop, Stefan;
- Harrison, Simon J.;
- NagaKrishna, Murthy;
- Dhuria, Shyeilla;
- Hindoyan, Antreas;
- McIver, Zach;
- Henary, Haby;
- Morrow, Phuong Khanh;
- Roberts, Andrew
Publication type:
Article
Addition of Cyclophosphamide "On Demand" to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma-A Retrospective Review of a Single-center Experience.
Published in:
2019
By:
- Alahmadi, Majed;
- Masih-Khan, Esther;
- Atenafu, Eshetu G.;
- Chen, Christine;
- Kukreti, Vishal;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Reece, Donna E.
Publication type:
journal article
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation.
Published in:
2018
By:
- Chan, Henry;
- Phillips, Madeline;
- Maganti, Manjula;
- Farooki, Sophia;
- Piza Rodriguez, Giovanni;
- Masih-Khan, Esther;
- Chen, Christine;
- Prica, Anca;
- Reece, Donna;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Kukreti, Vishal
Publication type:
journal article
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
Published in:
2017
By:
- van Beers, Erik H.;
- van Vliet, Martin H.;
- Kuiper, Rowan;
- de Best, Leonie;
- Anderson, Kenneth C.;
- Chari, Ajai;
- Jagannath, Sundar;
- Jakubowiak, Andrzej;
- Kumar, Shaji K.;
- Levy, Joan B.;
- Auclair, Daniel;
- Lonial, Sagar;
- Reece, Donna;
- Richardson, Paul;
- Siegel, David S.;
- Stewart, A. Keith;
- Trudel, Suzanne;
- Vij, Ravi;
- Zimmerman, Todd M.;
- Fonseca, Rafael
Publication type:
journal article
Targeted Sequencing of Circulating Cell-free DNA in Multiple Myeloma Allows Analysis of Somatic Mutations, Copy Number Aberrations, and Translocations.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e93, doi. 10.1016/j.clml.2017.03.167
By:
- Kis, Olena;
- Chow, Signy;
- Kaedbey, Rayan;
- Danesh, Arnavaz;
- Dowar, Mark;
- Li, Tiantian;
- Li, Zhihua;
- Liu, Jessica;
- Masih-Khan, Esther;
- Mulder, David;
- Zhang, Tong;
- Bratman, Scott;
- Oza, Amit;
- Kamel-Reid, Suzanne;
- Pugh, Trevor;
- Trudel, Suzanne
Publication type:
Article
Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma.
Published in:
2016
By:
- Reece, Donna E.;
- Trieu, Young;
- Masih-Khan, Esther;
- Atenafu, Eshetu G.;
- Chen, Christine;
- Prica, Anca;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Kukreti, Vishal
Publication type:
journal article
An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 310, doi. 10.1016/j.clml.2012.08.003
By:
- Jagannath, Sundar;
- Vij, Ravi;
- Stewart, A. Keith;
- Trudel, Suzanne;
- Jakubowiak, Andrzej J.;
- Reiman, Tony;
- Somlo, George;
- Bahlis, Nizar;
- Lonial, Sagar;
- Kunkel, Lori A.;
- Wong, Alvin;
- Orlowski, Robert Z.;
- Siegel, David S.
Publication type:
Article
Rapidity and Quality of Response to Steroid-Based Induction Therapy, Without the Addition of Novel Agents, Does Not Affect Post Transplant Outcomes in Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 25, doi. 10.1016/j.clml.2012.08.008
By:
- Prica, Anca;
- Trieu, Young;
- Wei Xu;
- Reece, Donna E.;
- Trudel, Suzanne;
- Kukreti, Vishal;
- Chen, Christine
Publication type:
Article
research paper Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma.
Published in:
British Journal of Haematology, 2004, v. 124, n. 5, p. 595, doi. 10.1111/j.1365-2141.2004.04814.x
By:
- Peterson, Joshua L.;
- Zhihua Li;
- Xiao-Yan Wen, Joshua L.;
- Masih-Khan, Esther;
- Hong Chang;
- Pollett, Jonathan B.;
- Trudel, Suzanne;
- Stewart, A. Keith
Publication type:
Article
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.
Published in:
Cold Spring Harbor Molecular Case Studies, 2023, v. 9, n. 2, p. 1, doi. 10.1101/mcs.a006249
By:
- Croucher, Danielle C.;
- Devasia, Anup Joseph;
- Abelman, D.;
- Mahdipour-Shirayeh, Ali;
- Zhihua Li;
- Erdmann, Natalie;
- Tiedemann, Rodger;
- Pugh, Trevor J.;
- Trudel, Suzanne
Publication type:
Article
Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients.
Published in:
Cancer Medicine, 2017, v. 6, n. 1, p. 3, doi. 10.1002/cam4.799
By:
- Kotchetkov, Rouslan;
- Masih‐Khan, Esther;
- Chu, Chia‐Min;
- Atenafu, Eshetu G.;
- Chen, Christine;
- Kukreti, Vishal;
- Trudel, Suzanne;
- Tiedemann, Rodger;
- Reece, Donna E.
Publication type:
Article
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26598-w
By:
- Croucher, Danielle C.;
- Richards, Laura M.;
- Tsofack, Serges P.;
- Waller, Daniel;
- Li, Zhihua;
- Wei, Ellen Nong;
- Huang, Xian Fang;
- Chesi, Marta;
- Bergsagel, P. Leif;
- Sebag, Michael;
- Pugh, Trevor J.;
- Trudel, Suzanne
Publication type:
Article
Phase I- II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma.
Published in:
British Journal of Haematology, 2015, v. 168, n. 1, p. 46, doi. 10.1111/bjh.13100
By:
- Reece, Donna E.;
- Masih‐Khan, Esther;
- Atenafu, Eshetu G.;
- Jimenez‐Zepeda, Victor H.;
- Anglin, Peter;
- Chen, Christine;
- Kukreti, Vishal;
- Mikhael, Joseph R.;
- Trudel, Suzanne
Publication type:
Article
Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.
Published in:
British Journal of Haematology, 2014, v. 167, n. 4, p. 563, doi. 10.1111/bjh.13004
By:
- Reeder, Craig B.;
- Reece, Donna E.;
- Kukreti, Vishal;
- Mikhael, Joseph R.;
- Chen, Christine;
- Trudel, Suzanne;
- Laumann, Kristina;
- Vohra, Harjot;
- Fonseca, Rafael;
- Bergsagel, P. Leif;
- Leis, Jose F.;
- Tiedemann, Rodger;
- Stewart, A. Keith
Publication type:
Article
Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.
Published in:
British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.13004
By:
- Reeder, Craig B.;
- Reece, Donna E.;
- Kukreti, Vishal;
- Mikhael, Joseph R.;
- Chen, Christine;
- Trudel, Suzanne;
- Laumann, Kristina;
- Vohra, Harjot;
- Fonseca, Rafael;
- Bergsagel, P. Leif;
- Leis, Jose F.;
- Tiedemann, Rodger;
- Stewart, A. Keith
Publication type:
Article
Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2014, v. 165, n. 5, p. 731, doi. 10.1111/bjh.12785
By:
- Chen, Christine I.;
- Paul, Harminder;
- Wang, Trina;
- Le, Lisa W.;
- Dave, Nimisha;
- Kukreti, Vishal;
- Nong Wei, Ellen;
- Lau, Anthea;
- Bergsagel, Peter Leif;
- Trudel, Suzanne
Publication type:
Article
Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution.
Published in:
British Journal of Haematology, 2014, v. 164, n. 5, p. 722, doi. 10.1111/bjh.12673
By:
- Jimenez‐Zepeda, Victor H.;
- Franke, Norman;
- Reece, Donna E.;
- Trudel, Suzanne;
- Chen, Christine;
- Delgado, Diego H.;
- Winter, Andrew;
- Mikhael, Joseph R.;
- Tiedemann, Rodger;
- Kukreti, Vishal
Publication type:
Article
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.
Published in:
British Journal of Haematology, 2013, v. 162, n. 4, p. 483, doi. 10.1111/bjh.12414
By:
- Chen, Christine I.;
- Masih‐Khan, Esther;
- Jiang, Haiyan;
- Rabea, Ahmed;
- Cserti‐Gazdewich, Christine;
- Jimenez‐Zepeda, Victor H.;
- Chu, Chia‐Min;
- Kukreti, Vishal;
- Trudel, Suzanne;
- Tiedemann, Rodger;
- Tsang, Richard;
- Reece, Donna E.
Publication type:
Article
D(T) PACE as salvage therapy for aggressive or refractory multiple myeloma.
Published in:
British Journal of Haematology, 2013, v. 161, n. 6, p. 802, doi. 10.1111/bjh.12325
By:
- Gerrie, Alina S.;
- Mikhael, Joseph R.;
- Cheng, Lu;
- Jiang, Haiyan;
- Kukreti, Vishal;
- Panzarella, Tony;
- Reece, Donna;
- Stewart, Keith A.;
- Trieu, Young;
- Trudel, Suzanne;
- Chen, Christine I.
Publication type:
Article
Differential regulation of FGFR3 by PTPN1 and PTPN2.
Published in:
Proteomics, 2015, v. 15, n. 2/3, p. 419, doi. 10.1002/pmic.201400259
By:
- St‐Germain, Jonathan R.;
- Taylor, Paul;
- Zhang, Wen;
- Li, Zhihua;
- Ketela, Troy;
- Moffat, Jason;
- Neel, Benjamin G.;
- Trudel, Suzanne;
- Moran, Michael F.
Publication type:
Article
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.
Published in:
Life Science Alliance, 2023, v. 6, n. 1, p. 1, doi. 10.26508/lsa.202201543
By:
- Chow, Signy;
- Kis, Olena;
- Mulder, David T.;
- Danesh, Arnavaz;
- Bruce, Jeff;
- Wang, Ting Ting;
- Reece, Donna;
- Bhalis, Nizar;
- Neri, Paola;
- Sabatini, Peter J. B.;
- Keats, Jonathan;
- Trudel, Suzanne;
- Pugh, Trevor J.
Publication type:
Article
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Published in:
Nature Communications, 2017, v. 8, n. 5, p. 15086, doi. 10.1038/ncomms15086
By:
- Kis, Olena;
- Kaedbey, Rayan;
- Chow, Signy;
- Danesh, Arnavaz;
- Dowar, Mark;
- Li, Tiantian;
- Li, Zhihua;
- Liu, Jessica;
- Mansour, Mark;
- Masih-Khan, Esther;
- Zhang, Tong;
- Bratman, Scott V.;
- Oza, Amit M.;
- Kamel-Reid, Suzanne;
- Trudel, Suzanne;
- Pugh, Trevor J.
Publication type:
Article
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.
Published in:
Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809
By:
- Lonial, Sagar;
- Lee, Hans C.;
- Badros, Ashraf;
- Trudel, Suzanne;
- Nooka, Ajay K.;
- Chari, Ajai;
- Abdallah, Al‐Ola;
- Callander, Natalie;
- Sborov, Douglas;
- Suvannasankha, Attaya;
- Weisel, Katja;
- Voorhees, Peter M.;
- Womersley, Lynsey;
- Baron, January;
- Piontek, Trisha;
- Lewis, Eric;
- Opalinska, Joanna;
- Gupta, Ira;
- Cohen, Adam D.
Publication type:
Article
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.
Published in:
American Journal of Hematology, 2014, v. 89, n. 4, p. 363, doi. 10.1002/ajh.23640
By:
- Minden, Mark D.;
- Hogge, Donna E.;
- Weir, Scott J.;
- Kasper, Jim;
- Webster, Debra A.;
- Patton, Lavonne;
- Jitkova, Yulia;
- Hurren, Rose;
- Gronda, Marcela;
- Goard, Carolyn A.;
- Rajewski, Lian G.;
- Haslam, John L.;
- Heppert, Kathleen E.;
- Schorno, Kevin;
- Chang, Hong;
- Brandwein, Joseph M.;
- Gupta, Vikas;
- Schuh, Andre C.;
- Trudel, Suzanne;
- Yee, Karen W. L.
Publication type:
Article
Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.
Published in:
American Journal of Hematology, 2013, v. 88, n. 4, p. 337, doi. 10.1002/ajh.23394
By:
- Kukreti, Vishal;
- Masih-Khan, Esther;
- Young, Trieu;
- Chu, Chia-Min;
- Jiang, Haiyun;
- Trudel, Suzanne;
- Chen, Christine;
- Jimenez-Zepeda, Victor;
- Reece, Donna E.
Publication type:
Article
Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy.
Published in:
American Journal of Hematology, 2012, v. 87, n. 8, p. 822, doi. 10.1002/ajh.23235
By:
- Jimenez-Zepeda, Victor H.;
- Trudel, Suzanne;
- Winter, Andrew;
- Reece, Donna E.;
- Chen,, Christine;
- Kukreti, Vishal
Publication type:
Article
Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation.
Published in:
American Journal of Hematology, 2011, v. 86, n. 10, p. 873, doi. 10.1002/ajh.22115
By:
- Jimenez-Zepeda, Victor H.;
- Trudel, Suzanne;
- Reece, Donna E.;
- Chen, Christine;
- Rabea, Ahmed M.;
- Kukreti, Vishal
Publication type:
Article
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01212-0
By:
- Mukhopadhyay, Pralay;
- Abdullah, Hesham A.;
- Opalinska, Joanna B.;
- Paka, Prani;
- Richards, Eric;
- Weisel, Katja;
- Trudel, Suzanne;
- Mateos, Maria-Victoria;
- Dimopoulos, Meletios Athanasios;
- Lonial, Sagar
Publication type:
Article
Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains.
Published in:
European Journal of Haematology, 2022, v. 108, n. 3, p. 204, doi. 10.1111/ejh.13726
By:
- Lebel, Eyal;
- Li, Xuan;
- Paul, Harminder;
- Masih‐Khan, Esther;
- Bhella, Sita;
- Chen, Christine;
- Prica, Anca;
- Reece, Donna;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Kukreti, Vishal
Publication type:
Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
Published in:
European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
By:
- Zangari, Maurizio;
- Aujay, Monette;
- Fenghuang Zhan;
- Hetherington, Kristina L.;
- Berno, Tamara;
- Vij, Ravi;
- Jagannath, Sundar;
- Siegel, David;
- Stewart, A. Keith;
- Wang, Luhua;
- Orlowski, Robert Z.;
- Belch, Andrew;
- Jakubowiak, Andrzej;
- Somlo, George;
- Trudel, Suzanne;
- Bahlis, Nizar;
- Lonial, Sagar;
- Singhal, Seema;
- Kukreti, Vishal;
- Tricot, Guido
Publication type:
Article
Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules.
Published in:
ChemMedChem, 2011, v. 6, n. 8, p. 1459, doi. 10.1002/cmdc.201100194
By:
- Fletcher, Steven;
- Page, Brent D. G.;
- Zhang, Xialoei;
- Yue, Peibin;
- Li, Zhi Hua;
- Sharmeen, Sumaiya;
- Singh, Jagdeep;
- Zhao, Wei;
- Schimmer, Aaron D.;
- Trudel, Suzanne;
- Turkson, James;
- Gunning, Patrick T.
Publication type:
Article
Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.
Published in:
2012
By:
- Jimenez-Zepeda, Victor;
- Vajpeyi, Rajkumar;
- John, Rohan;
- Trudel, Suzanne
Publication type:
Report
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Published in:
Leukemia & Lymphoma, 2021, v. 62, n. 7, p. 1721, doi. 10.1080/10428194.2021.1876864
By:
- Khan, Sahar;
- LeBlanc, Richard;
- Gyger, Martin;
- White, Darrell;
- Kaufman, Johnathan;
- Jazubowiak, Andrzej;
- Gul, Engin;
- Paul, Harminder;
- Le, Lisa W.;
- Lau, Anthea;
- Li, Zhihua;
- Trudel, Suzanne
Publication type:
Article
Syngeneic transplants for multiple myeloma – a single center experience and review of the literature.
Published in:
2020
By:
- Lebel, Eyal;
- Prica, Anca;
- Bhella, Sita;
- Kukreti, Vishal;
- Tiedemann, Rodger;
- Trudel, Suzanne;
- Reece, Donna;
- Chen, Christine
Publication type:
Letter
An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines.
Published in:
Leukemia & Lymphoma, 2020, v. 61, n. 8, p. 1860, doi. 10.1080/10428194.2020.1747064
By:
- Chen, Christine I.;
- Cao, Yanshuo;
- Trudel, Suzanne;
- Reece, Donna E.;
- Kukreti, Vishal;
- Tiedemann, Rodger;
- Prica, Anca;
- Paul, Harminder;
- Le, Lisa W.;
- Levina, Olga;
- Kakar, Sumeet;
- Lau, Anthea;
- Chen, Hongzhuan;
- Chen, Eric
Publication type:
Article
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL).
Published in:
Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 980, doi. 10.1080/10428194.2018.1508669
By:
- Chen, Christine I.;
- Paul, Harminder;
- Snitzler, Susi;
- Kakar, Sumeet;
- Le, Lisa W.;
- Wei, Ellen N.;
- Lau, Anthea;
- Johnston, James B.;
- Gibson, Spencer B.;
- Queau, Michelle;
- Spaner, David;
- Croucher, Danielle;
- Sherry, Barbara;
- Trudel, Suzanne
Publication type:
Article